Stimulation of quiescent mouse ®broblasts with TGF-b1 and certain other growth factors result in cooperative activation of tissue factor (TF) gene transcription, an event accompanied by the rapid entry of c-Fos into speci®c AP-1 DNA-binding complexes (Felts et al. (1995) Biochemistry 34, 12355 ± 12362). Here, we demonstrate that the ability of TGF-b1 to synergistically activate TF transcription in serum-stimulated ®broblasts is dependent upon both c-Fos and a promoter-speci®c factor with functional properties characteristic of transcriptional coactivators. Inhibition of TF promoter activity by an adenovirus E1A mutant deleted in an essential CREB binding protein (CBP) interaction domain suggests that this factor is distinct from the CBP/p300 family of transcriptional coactivators. Importantly, the ability of this factor to mediate molecular interactions with c-Fos required for transcriptional synergism is directly linked to TGF-b1 signaling. These data suggest a model in which a component of the TF basal transcription complex functions to integrate multiple signaling pathways required for full transcriptional activation of TF in ®broblasts.
Introduction
Cooperativity among growth factors in¯uences a diversity of physiological events including embryogenesis, wound healing, immune responses, and carcinogenesis. Transforming growth factor-b1 (TGF-b1) is the prototypic example of a family of growth factors whose pleiotropic eects are strongly dependent upon the modifying in¯uence of other growth factors or hormones present in the cellular micro environment (reviewed in Sporn and Roberts, 1988 ). An understanding of this`contextual' aspect at the molecular level is essential to understanding the full range of biological eects induced by members of the TGF-b family.
TGF-b1 has been shown to modulate, either positively or negatively, speci®c gene expression induced by other growth factors such as epidermal growth factor (EGF). In some cases, TGF-b1 induces changes in the number or anity of cell surface receptors for a second factor (Takehara et al., 1987 and references therein). However, in other cases, TGFb1 appears to modify gene expression directly (Ranganathan and Getz, 1990 and references therein). In mouse ®broblasts, TGF-b1 synergistically activates EGF-dependent transcription in the absence of detectable alterations in EGF receptors (Ranganathan and Getz, 1990) . This observation suggests that TGFb1 may induce the formation of stable transcription complexes whose functioning can be potentiated by cooperating growth factors. One of the genes tested in this previous study, a serum-inducible clone termed c70, was subsequently found to encode tissue factor (TF), the cellular initiator of the protease blood coagulation cascade (Ranganathan et al., 1991) . Tissue factor is a cell-surface receptor and essential cofactor for plasma coagulation factor VII/VIIa and plays a central role in the maintenance of hemostasis (reviewed in Edgington et al., 1991) . Inappropriate expression of TF has been speci®cally implicated in a variety of pathologies including atherosclerosis, disseminated intravascular coagulation, E. coli-induced septic shock, and tumorigenesis (Wilcox et al., 1989; Warr et al., 1990; Taylor Jr et al., 1991; Rao, 1992) .
Recently, TGF-b1 was shown to cooperate with other growth factors, including platelet-derived growth factor (PDGF) and acidic ®broblast growth factor (FGFa), to activate TF promoter activity synergistically (Felts et al., 1995) . Two activator protein-1 (AP-1) DNA-binding sites, located 200 ± 220 bp upstream of the transcription start site, were found to be both necessary and sucient to synergistically activate a minimal TF promoter. TGF-b1-cooperating factors, but not TGF-b1 itself, stimulated the rapid entry of cFos into speci®c AP-1 DNA-binding complexes, suggesting that AP-1 heterodimers containing c-Fos were essential to transcriptional synergism.
The present study extends these observations by con®rming that c-Fos is indeed essential to the synergistic activation of TF promoter activity in cells treated with a combination of TGF-b1 and serum. However, the ability of c-Fos to synergistically stimulate transcription was found to require a TGFb1-regulated component of the TF basal transcription complex with functional properties characteristic of a transcriptional coactivator. This component exhibits speci®city towards the TF promoter and appears distinct from the CREB binding protein (CBP)/p300 family of transcriptional coactivators (Kwok et al., 1994; Lundblad et al., 1995; Arias et al., 1994; Arany et al., 1994) . However, like CBP/p300, this component appears to functionally interact with both c-Fos and the adenovirus E1A 12S gene product (Bannister and Kouzarides, 1995; Lundblad et al., 1995; Arany et al., 1995) . These data lead us to propose a model in which an as yet unidenti®ed coactivator of c-Fos serves to coordinate TGF-b1 signaling cascades with those induced by other growth factors to synergistically stimulate transcription of the tissue factor gene in ®broblasts.
Results
TGF-b1 cooperates with serum to synergistically stimulate AP1-dependent TF promoter activity Previous studies have shown that the AP-1 DNAbinding sites in the TF promoter were both necessary and sucient to activate promoter activity in serumstimulated ®broblasts (Felts et al., 1995) . When applied singularly, puri®ed growth factors such as TGF-b1 or PDGF had little eect on TF promoter activity. However, a combination of TGF-b1 and other specific growth factors cooperatively activated TF promoter activity. Cooperativity was dependent upon TGF-b1 as combinations of growth factors lacking TGF-b1 failed to cooperatively activate TF promoter activity (Felts et al., 1995 and data not shown) . Because cells in vivo are likely to encounter TGF-b1 in combination with a host of dierent serum factors, we tested whether promoter activity would be dierentially aected by serum stimulation versus serum and TGF-b1 costimulation. Two dierent AP1-dependent promoter constructs were tested. AP1-TF60 consists of the TF AP-1 elements linked to the mouse TF promoter deleted to 760 and containing only the TATA box as a recognizable sequence motif (Felts et al., 1995; Mackman et al., 1992) . AP1-tk consists of the same TF AP-1 elements linked to the heterologous tk promoter. These DNAs were transfected into AKR-2B ®broblasts, the cells were rendered quiescent by serum deprivation, then restimulated with serum, TGF-b1, or both.
As shown in Figure 1 , TGF-b1 alone was, at best, a weak stimulator of both AP1-TF60 and AP1-tk promoter activity. However, serum stimulated both promoters approximately ®ve-to sevenfold. Interestingly, the combination of serum and TGF-b1 stimulated AP1-tk in an additive fashion (approximately 10-fold) whereas AP1-TF60 was stimulated synergistically (30-fold). A wild-type TF promoter (TF264CAT, Felts et al., 1995) , was also synergistically activated by TGF-b1 and serum (data not shown), demonstrating that synergism was not due to an altered placement of the AP-1 elements. Neither basal promoter (TF60 nor tk) was stimulated under any of these conditions, demonstrating a strict requirement for the TF AP-1 DNA-binding sites.
Transcriptional synergism requires c-Fos
Stimulation of ®broblasts with serum or certain puri®ed growth factors results in a rapid recruitment of c-Fos into heterodimeric TF AP-1 DNA-binding complexes with Jun proteins (Felts et al., 1995) . To test whether cFos plays an essential role in the synergistic activation of TF promoter activity, AP1-TF60 and AP1-tk were transfected into ®broblasts derived from a c-Fos knockout mouse (Fos
7/7
). These cells exhibit normal levels of other Fos-and Jun-family members, but are speci®cally devoid of c-Fos (Hu et al., 1994) . As shown in Figure 1 , synergistic stimulation of the AP1-TF60 construct was abolished in Fos 7/7 cells. Instead, both AP1-TF60 and AP1-tk exhibited an additive response to costimulation with TGF-b1 and serum. Endogenous TF activity was similarly impaired in Fos extracts did not increase upon stimulation with serum or serum plus TGF-b1. These data also con®rmed the absence of c-Fos in TF AP-1 DNA-binding complexes from these cells as evidenced by the inability of a c-Fos-speci®c antibody to Figure 1 Synergistic activation of AP1-dependent transcription by serum plus TGF-b1 is promoter speci®c and c-Fos-dependent. AP1-TF60, AP1-tk, or the basal promoter controls were transiently transfected into AKR-2B ®broblasts or ®broblasts derived from a Fos-de®cient mouse (Fos
). After being rendered quiescent for 36 ± 48 h, the transfectants were stimulated with TGF-b1 (T), serum (FCS), or both (FCS+T) for 5 h. Fold induction of CAT protein was calculated for each DNA from parallel quiescent and stimulated transfectants and is the average, plus or minus the range, of duplicate plates AKR-2B or Fos 7/7 cells or cells stimulated for 30 min with serum (FCS) or serum plus TGF-b1 (FCS+T) were prepared and an equal amount (2.5 mg) of extract protein was assayed for AP-1 DNA-binding activity by gel mobility shift using a DNA fragment containing the two TF AP-1 elements. Large-scale reactions were incubated for 20 min at room temperature. Aliquots of the reaction were then incubated for 1 h at 48C with 1 ml of each antibody as indicated prior to loading onto the gel. Complexes in lanes 1 ± 9 were exposed to BioMax MR ®lm (Kodak) for 18 h; complexes in lanes 10 ± 19 were exposed to the faster XAR-5 ®lm (Kodak) for 72 h supershift TF AP-1 complexes (compare lanes 3 and 7 with lanes 13 and 17). However, an antibody that recognizes all Fos family members gave a quantitative supershift of the AP-1 complexes from Fos 7/7 extracts (lanes 14 and 18). This result indicates that these TF AP-1 DNA-binding complexes consisted largely of heterodimers between Jun proteins and some other member of the Fos family.
Overexpression of c-Fos speci®cally inhibits synergistic stimulation of AP1-TF60 promoter activity Transcriptional activating domains have been shown to function by direct protein ± protein interaction with various components of the basal transcription complex, or with coactivators that function as intermediates (reviewed in Gill and Tjian, 1992; Pugh, 1996) . Overexpression of activating proteins can result in the inhibition of promoter activity by virtue of sequestering such components into inactive complexes (Ptashne, 1988) . The observation that AP-1-directed transcriptional synergism was promoter-speci®c and c-Fos dependent (Figure 1 ), suggested that c-Fos-containing heterodimers might interact dierently with components of the TF and tk basal transcription apparatus. To test this hypothesis, each AP-1 promoter construct was cotransfected into AKR-2B ®broblasts with increasing amounts of a c-Fos expression vector and a constant amount of a JunD expression vector. JunD is a prominent component of TF AP-1 DNA-binding complexes in these cells (Felts et al., 1995) . The eect on promoter activity was determined in both quiescent cells and cells stimulated with TGF-b1 and serum. As shown in Figure 3a , cotransfection with increasing amounts of RSV-cFos ®rst activated, then inhibited AP1-tk promoter activity in a manner that was roughly proportional in quiescent and stimulated cells. As a result, AP1-tk inducibility (fold induction over basal levels) by TGF-b1 and serum was largely unaected (Figure 3b ). In contrast, cotransfection with RSV-cFos stimulated AP1-TF60 activity in quiescent cells but did not produce a proportional eect in stimulated cells (Figure 3a) . Thus, c-Fos appears to speci®cally inhibit a component(s) required for activated, but not basal transcription. As a result, promoter inducibility in response to TGF-b1 and serum was dramatically decreased (Figure 3b) . Indeed, at the two highest levels of c-Fos input, the dierential inducibility of the two promoter constructs was completely abrogated. These eects were not observed when c-Fos was cotransfected in the absence of JunD (data not shown), implying that c-Fos interacts with components of the two basal transcription complexes while in the form of AP-1 heterodimers. These data demonstrate that c-Fos dierentially interacts with components of the TF and tk basal transcription complexes, and further suggest that such interactions may underlie the dierential inducibility of these two promoters in cells stimulated with TGF-b1 and serum (Figure 1 ).
E1A 12S represses AP1-TF60, independent of CBP/p300 binding Bannister and Kouzarides (1995) showed that CREB binding protein (CBP) binds c-Fos in vitro and can stimulate GAL4-Fos transactivation in vivo. In addition, the c-Fos activation function could be repressed by the adenovirus E1A 12S gene product, but not by a mutant de®cient in CBP binding. We therefore asked whether E1A 12S could repress transcription from AP1-TF60 and AP1-tk. The results in Figure  4 show that, indeed, cotransfection of either promoter construct with an E1A expression vector resulted in an inhibition of transcription in AKR-2B cells stimulated with TGF-b1 and serum. Cotransfection of an E1A mutant (D2 ± 36) de®cient in CBP/p300 binding (Barbeau et al., 1994) was much less eective in inhibiting AP1-tk promoter activity. However, this mutant E1A was still able to eectively repress AP1-TF60 promoter activity.
To con®rm the observed dierence in E1A action between the two AP1 promoter constructs, we tested whether coexpression of CBP would abrogate E1A-mediated repression of either AP1-tk or AP1-TF60. As shown in Figure 5a , cotransfection of increasing amounts of a CBP expression vector restored AP1-tk promoter activity in E1A-transfected cells, but had little eect on AP1-TF60 promoter repression. Similar results were obtained using an expression vector for the CBP-related coactivator, p300 (data not shown). TGF-b1 signaling induces a c-Fos-responsive state within the tissue factor basal promoter complex Collectively, the preceding data indicate that a promoter-speci®c component of the TF basal transcription complex is required for transcriptional synergism in cells stimulated with a combination of TGF-b1 and serum. However, they provide no insight as to whether the functional activity of this component is regulated by TGF-b1, serum, or both. To address this important issue, we devised a sequential addition protocol in which serum-starved cells transfected with AP1-TF60 were brie¯y exposed to TGF-b1 in serumfree medium, washed twice in serum-free medium lacking TGF-b1, then incubated for varying periods of time with the same medium to facilitate dissociation of any remaining receptor-bound TGF-b1. Following these treatments, cells were stimulated with medium containing 20% fetal calf serum to induce c-Foscontaining AP-1 DNA-binding complexes (Felts et al., 1995) . As shown in Figure 6 , a 10 min exposure to TGF-b1, followed by a 30 min washout and serum stimulation, was as eective in stimulating AP1-TF60 promoter activity as simultaneous treatment with TGF-b1 and serum. However, as the TGF-b1 washout period was increased, promoter activity following serum-stimulation progressively declined towards that induced by serum alone. The potentiating eect of Figure 4 E1A (D2 ± 36) inhibits AP1-TF but not AP1-tk. AP1-TF60 (AP1-TF) or AP1-tk was cotransfected into AKR-2B ®broblasts with various amounts of CMV-E1A (12S wildtype (wt) or D2 ± 36 (mut)) CMVb was used to maintain a constant amount of DNA transfected. After being rendered quiescent for 36 ± 48 h, parallel transfectants were stimulated for 5 h with serum plus TGF-b1 as in Figure 1 . CAT expression from each promoter is expressed relative to itself when cotransfected with CMVb expression vector control. Error bars re¯ect the range of duplicate plates transfected Figure 5 CBP rescues E1A-inhibited AP1-tk but not E1A-inhibited or c-Fos-inhibited AP1-TF. (a) AP1-TF60 or AP1-tk was cotransfected into AKR-2B ®broblasts with CMV-E1A alone or along with various amounts (1, 3, 6, or 9 mg) of CMV-CBP. Empty CMVb expression vector was used as the control. After being rendered quiescent, parallel transfectants were stimulated for 5 h with serum plus TGF-b1 as in Figure 1 . (b) AP1-TF60 was cotransfected into AKR-2B ®broblasts with RSV-JunD (Control), RSV-JunD and RSV-cFos (+c-Fos), or RSV-JunD, RSV-cFos and increasing amounts (1, 3, or 6 mg) of CMV-CBP. The transfectants were rendered quiescent then restimulated as in a. Error bars re¯ect the range of duplicate plates transfected Figure 6 Synergistic stimulation of TF promoter activity by TGF-b1 and serum does not require simultaneous addition. AKR-2B cells were transfected with AP1-TF60, rendered quiescent as described in Figure 1 , then stimulated with TGFb1 (T), serum (FCS), or both as indicated below each bar. In the TGF-b1 washout experiments, cells were washed twice with serum free MCDB 402 media, then incubated in same for the indicated times (0.5 ± 6 h) prior to addition of serum. Error bars re¯ect the range of duplicate plates transfected TGF-b1 was no longer apparent following a 6 h incubation in medium lacking TGF-b1.
Because receptor-bound TGF-b1 may not be completely dissociated by the shorter incubation periods following the initial washout, we asked whether synergism would occur if serum addition preceded TGF-b1. As shown in Figure 7 , transient exposure to serum, followed by stimulation with TGFb1 had little eect on AP1-TF60 promoter activity. This was true even when the incubation period following the washout was omitted. When the order of addition was reversed (i.e. TGF-b1 then serum) strong synergism was again evident. Together, these data imply that the role of TGF-b1 signaling is to strongly potentiate the ability of the TF basal transcription apparatus to respond to stimulation by AP-1 DNA-binding complexes containing c-Fos.
Discussion
Extracellular stimuli such as polypeptide growth factors activate a spectrum of diverse intracellular signaling cascades, many of which target transcriptional activating proteins that mediate speci®c gene expression (Karin and Smeal, 1992) . To ensure appropriate cellular responses to a multi-growth factor environment, mechanisms must exist to integrate dierent growth factor-initiated signaling pathways at the molecular level. The data presented here, suggest that a component speci®cally associated with the TF basal promoter plays a key role in coordinating signaling cascades initiated in response to stimulation of ®broblasts with TGF-b1 and other growth factors present in serum.
Several lines of evidence suggest that this component may belong to a class of proteins termed transcriptional adaptors or coactivators (Gill and Tjian, 1992; Verrijzer et al., 1995) . Most importantly, the ability of TGF-b1 to synergistically activate transcription in serum-stimulated ®broblasts is strictly dependent upon the choice of basal promoter. When linked to identical upstream activating elements (i.e. the TF AP-1 DNAbinding sites) only the TF promoter displayed transcriptional synergism. Thus, general transcription factors common to both promoters are excluded as candidates for mediating transcriptional synergism. Moreover, an alternative model in which synergism is due solely to post-translational modi®cation of AP-1 components is unlikely because this would require that dierential modi®cation of AP-1 complexes occur within the context of identical recognition elements. While post-translational modi®cation of AP-1 may indeed be required for synergism, it cannot explain the dierential response of the two basal promoters used in this study.
Synergistic activation of the AP1-TF60 promoter is also highly dependent upon the presence of c-Fos in AP-1 heterodimers. In Fos 7/7 ®broblasts, heterodimers between Jun proteins and other Fos family members supported both basal transcription and an additive response to TGF-b1 and serum, but speci®cally lacked the ability to mediate a synergistic response. Moreover, synergistic activation of the AP1-TF60 promoter was inhibited by high levels of c-Fos, or by co-expression of the adenovirus E1A 12S protein. In contrast, overexpression of c-Fos had little eect on the additive inducibility of the AP1-tk promoter.
Collectively, these observations implicate both c-Fos and a TF basal promoter-speci®c coactivator as essential components of a mechanism responsible for the integration of signaling cascades induced by TGFb1 and serum components. Although c-Fos is known to interact with CPB, initially identi®ed as a coactivator of the cyclic AMP response element binding protein (CREB) (Arias et al., 1994; Kwok et al., 1994) , coexpression of CBP did not relieve inhibition of transcriptional synergism by c-Fos, nor did it relieve repression by E1A 12S . Moreover, a mutant E1A lacking an N-terminal domain required for CBP/ p300 binding was still able to repress AP1-TF60 promoter activity, further suggesting that the TF basal promoter-speci®c factor is not CBP or p300. Because this factor strongly potentiates the ability of cFos to stimulate transcription, we have provisionally termed it CAF, for coactivator of Fos.
It is important to note that our data do not exclude the participation of CBP in the transcriptional synergism displayed by the AP1-TF60 promoter, but only exclude CBP as a sole essential coactivator. Indeed, an attractive model is that the synergistic activation of the AP1-TF60 promoter results from the interaction of c-Fos with multiple coactivators. CBP has recently been shown to cooperate with steroid receptor coactivator-1 to stimulate estrogen receptor-dependent transcription (Smith et al., 1996) and a similar mechanism may be operative within the context of the TF promoter. The cFos protein contains at least ®ve Fos activation modules (FAMS) which have been shown to cooperate with each other to activate transcription (Metz et al., 1994; Abate et al., 1991) . The CBP binding region of c-Fos appears to span FAM4 and FAM5 (Bannister and Kouzarides, 1995) but interactions mediated by the other FAMS remain unknown. Because both c-Fos and E1A are also known to interact with the TATA binding protein (TBP) (Metz et al., 1994; Horikoshi et al., 1991; Song et al., 1995) , one possibility we considered is that a dual Figure 7 Synergism requires that TGF-b1 precedes serum addition. AKR-2B cells were transfected with AP1-TF60, rendered quiescent as described in Figure 1 , then stimulated with TGF-b1 (T), serum (FCS), or both as indicated below each bar. Washouts were performed as described in the legend to Figure 6 . Error bars re¯ect the range of duplicate plates transfected interaction of c-Fos with both CBP and TBP accounts for the synergistic activation of AP1-TF60. However, E1A residues required for TBP binding include Nterminal amino acid sequences 4 ± 25 (Song et al., 1995) and these are lacking in the D2 ± 36 E1A mutant that we used in this study. Because this mutant still repressed synergistic activation of AP1-TF60, synergism seems likely to involve the interaction of c-Fos with proteins other than CBP/p300 or TBP. Candidates which are not excluded by our data include members of the class of TBP-associated factors or TAFs (Chen et al., 1994; Sauer et al., 1995) , TFIIE, a basal promoter-speci®c factor (Holstege et al., 1995; Parvin et al., 1992) implicated in AP-1-dependent promoter activity (Martin et al., 1996) , and JAB1, a member of a new group of coactivators which function to increase the speci®city of gene activation by AP-1 proteins (Claret et al., 1996) .
Irrespective of whether CAF corresponds to a previously identi®ed coactivator, or is a novel protein, the ability of TGF-b1 to induce a c-Fosresponsive state in the absence of serum factors ( Figure  6 ) clearly implies that the functional activity of this component is speci®cally regulated by TGF-b1 signaling pathways. Several components of such pathways have recently been identi®ed (Shibuya et al., 1996; Yamaguchi et al., 1995) but known downsteam targets are few (Kramer et al., 1991; Alevizopoulos et al., 1995; Liu et al., 1996) . TGF-b1 could speci®cally signal modi®cations of CAF required for cFos interaction or, alternatively, could signal modifications of c-Fos that permit association with CAF. The ability of CBP to bind CREB, for example, is regulated by phosphorylation of CREB on serine 133 (Chrivia et al., 1993) and a similar mechanism could regulate the interaction between c-Fos and CAF. Resolution of this issue will require studies of c-Fos phosphorylation and will obviously be facilitated by the identi®cation and molecular cloning of CAF. In this regard, we are attempting to localize E1A domains which mediate CAF functional activity with a view towards utilizing this information to devise appropriate puri®cation and cloning strategies. Hu et al. (1994) have shown that several genes known to contain functional AP-1 sites are expressed normally in c-Fos 7/7 ®broblasts. However, growth factor-induced expression of two AP-1-dependent genes, stromelysin and type I collagenase, was severely impaired. Both stromelysin and collagenase have been implicated in tumor progression and metastasis (Hu et al., 1994 and references therein) , and recent data from several sources, including our laboratory, suggest that TF may also contribute to metastatic progression (Mueller et al., 1992; Bromberg et al., 1995; Vrana et al., 1996) . Because stromelysin AP-1 DNA-binding complexes, like TF-AP-1 DNA-binding complexes, were readily detected in extracts from Fos 7/7 cells, these authors speculated that the requirement for c-Fos likely re¯ected an interaction with a promoter-speci®c component of the stromelysin and collagenase basal transcription machinery (Hu et al., 1994) . It is possible that this is the same component detected in the present study. Collectively, these studies raise the interesting possibility that CAF or a family of CAFs may function to regulate c-Fos-dependent expression of a class of genes that play a role in the metastatic dissemination of tumor cells. If so, such promoter-speci®c transcriptional coactivating proteins could become attractive targets for therapeutic strategies designed to inhibit the establishment of metastatic lesions.
Materials and methods
Cell culture, transfection and CAT assay AKR-2B mouse ®broblasts were maintained at 378C and 5% CO 2 and grown to con¯uence in McCoy's 5A medium (Gibco) containing 5% fetal bovine serum (Hyclone) and Pen-Strep (Gibco). Fos 7/7 cells (obtained from B Spiegelman; Hu et al., 1994) were maintained in DMEM (Whitaker) containing 10% fetal bovine serum and PenStrep. Transient transfections of AKR-2B cells were performed using DEAE-Dextran and a total of 15 mg plasmid DNA per 1610 6 cells as described previously (Felts et al., 1995) . The transfected cells were allowed to recover in growth medium containing 10% serum for 5 ± 6 h. The cells were then washed and allowed to quiesce in serum-free medium (MCBD402, JRH Biosciences) for 36 ± 48 h. Fos-de®cient cells were transfected using 10 mg of DNA and 20 ml Lipofectamine (Gibco-BRL) per 1610 6 cells in Opti-MEM as recommended by the manufacturer. After 5 ± 6 h incubation, the transfection medium was removed and replaced with MCDB402 for 36 ± 48 h. For both cell types, duplicate plates of cells were restimulated for 5 h in fresh MCDB402 medium containing the appropriate stimulus (FCS=20% (v/v) serum, T=5 ng/ml TGF-b1). TGF-b1 (human recombinant) was obtained from Austral Biologicals. Cellular extracts were prepared and equal amounts of cellular protein were assayed for CAT protein by CAT ELISA (Boehringer).
DNA constructs
The AP1-dependent reporter constructs were described previously (Felts et al., 1995) . Brie¯y, an oligonucleotide containing both AP-1 DNA-binding sites from the mouse tissue factor promoter 5'-TTGAATCACGGTTGAGT-CAC-3', along with restriction sites to facilitate cloning, was inserted into either pBLCAT2 (tkCAT) or a pBLCAT3 derivative containing a mouse tissue factor minimal promoter sequences 760 to +15 (TF60CAT).
The mammalian expression vectors RSV-JunD and RSVc-Fos were kindly provided by H Iba (Suzuki et al., 1991) . RSV-Neo was used as control DNA to maintain a constant amount of DNA transfected. The expression vectors for wildtype (pCMV12SE1A) and mutant E1A (D2 ± 36) were kindly provided by J Nevins. The vectors for CBP (pCMXCBP) and p300 (pCMVbP300) were obtained from M Montminy. The empty vector pCMVb (Clonetech) was used to control for constant amount of DNA transfected.
Gel mobility shifts
Nuclear extracts were prepared from quiescent or stimulated AKR-2B or Fos 7/7 cells and gel mobility shift assays were carried out as described previously (Felts et al., 1995) . Antibodies used for AP-1 supershift analyses were obtained from Santa Cruz (the c-Fos-speci®c antibody cFos (4)-G; the broadly-reactive c-Fos (K-25)-G; the broadly-reactive c-Jun (D)-G). manuscript. This work was supported by an individual
